
CRDL
Healthcare · Drug Manufacturers - Specialty & Generic · $127.7M market cap
$1.00-0.04 (-3.8%)Nov 13, 4:21 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -8.1% over 90 days · 30-day revisions 1 up, 2 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 12, 2026 | After the close | -0.06 | -0.08 | -33.3% |
| Aug 12, 2026 | Time not confirmed | -0.09 | -0.04 | +55.6% |
| Mar 31, 2026 | After the close | -0.11 | -0.07 | +36.4% |
| Nov 13, 2025 | After the close | -0.10 | -0.12 | -20.0% |
| Aug 14, 2025 | After the close | -0.12 | -0.10 | +16.7% |
| May 14, 2025 | After the close | -0.13 | -0.10 | +23.1% |
| Mar 31, 2025 | After the close | -0.12 | -0.09 | +22.9% |
| Nov 14, 2024 | After the close | -0.11 | -0.18 | -63.6% |
| Aug 12, 2024 | After the close | -0.13 | -0.10 | +23.1% |
| May 14, 2024 | After the close | -0.10 | -0.14 | -40.0% |
| Mar 28, 2024 | After the close | -0.09 | -0.09 | 0.0% |
| Nov 14, 2023 | After the close | -0.12 | -0.09 | +25.0% |
| Aug 10, 2023 | After the close | -0.12 |
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of…
| -0.12 |
| 0.0% |
| May 15, 2023 | After the close | -0.15 | -0.11 | +26.7% |
| Mar 30, 2023 | After the close | -0.15 | -0.12 | +20.0% |
| Nov 10, 2022 | After the close | -0.14 | -0.13 | +7.1% |
| Aug 10, 2022 | After the close | -0.15 | -0.10 | +33.3% |
| May 16, 2022 | After the close | -0.17 | -0.14 | +17.6% |
| Mar 22, 2022 | Time not confirmed | -0.14 | -0.11 | +21.4% |
| Nov 16, 2021 | Before the open | -0.18 | -0.18 | -0.2% |
| Aug 16, 2021 | After the close | -0.14 | -0.15 | -7.1% |
| May 16, 2021 | After the close | -0.14 | -0.26 | -85.7% |
| Mar 31, 2021 | Before the open | -0.12 | -0.15 | -25.0% |
| Nov 12, 2020 | After the close | -0.09 | -0.13 | -44.4% |
| Aug 13, 2020 | After the close | 0.00 | -0.10 | — |
| May 13, 2020 | After the close | -0.16 | -0.11 | +31.3% |
| Mar 26, 2020 | After the close | -0.13 | -0.12 | +7.7% |
| Nov 11, 2019 | After the close | 0.00 | -0.09 | — |
| Aug 13, 2019 | Before the open | 0.00 | -0.10 | — |
| May 8, 2019 | After the close | -0.09 | -0.13 | -44.4% |
| Mar 28, 2019 | After the close | 0.00 | -0.10 | — |
| Dec 31, 2018 | Time not confirmed | 0.00 | -0.41 | — |
| Sep 30, 2018 | Time not confirmed | 0.00 | -0.25 | — |
| Jun 30, 2018 | Time not confirmed | 0.00 | -0.07 | — |
| Mar 31, 2018 | Time not confirmed | 0.00 | -0.03 | — |